Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters.

Hatiboglu G, Popeneciu V, Bonekamp D, Burtnyk M, Staruch R, Pahernik S, Tosev G, Radtke JP, Motsch J, Schlemmer HP, Hohenfellner M, Nyarangi-Dix JN.

World J Urol. 2019 May 6. doi: 10.1007/s00345-019-02784-w. [Epub ahead of print]

PMID:
31062122
2.

A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.

Maas MC, Litjens GJS, Wright AJ, Attenberger UI, Haider MA, Helbich TH, Kiefer B, Macura KJ, Margolis DJA, Padhani AR, Selnæs KM, Villeirs GM, Fütterer JJ, Scheenen TWJ.

Invest Radiol. 2019 Apr 3. doi: 10.1097/RLI.0000000000000558. [Epub ahead of print]

PMID:
30946180
3.

Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.

Kooreman ES, van Houdt PJ, Nowee ME, van Pelt VWJ, Tijssen RHN, Paulson ES, Gurney-Champion OJ, Wang J, Koetsveld F, van Buuren LD, Ter Beek LC, van der Heide UA.

Radiother Oncol. 2019 Apr;133:156-162. doi: 10.1016/j.radonc.2019.01.011. Epub 2019 Jan 28.

PMID:
30935572
4.

Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease.

Walser E, Nance A, Ynalvez L, Yong S, Aoughsten JS, Eyzaguirre EJ, Williams SB.

J Vasc Interv Radiol. 2019 Mar;30(3):401-409.e2. doi: 10.1016/j.jvir.2018.09.016.

PMID:
30819483
5.

Multiparametric MRI and radiomics in prostate cancer: a review.

Sun Y, Reynolds HM, Parameswaran B, Wraith D, Finnegan ME, Williams S, Haworth A.

Australas Phys Eng Sci Med. 2019 Mar;42(1):3-25. doi: 10.1007/s13246-019-00730-z. Epub 2019 Feb 14.

PMID:
30762223
6.

Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.

Shah TT, Peters M, Eldred-Evans D, Miah S, Yap T, Faure-Walker NA, Hosking-Jervis F, Thomas B, Dudderidge T, Hindley RG, McCracken S, Greene D, Nigam R, Valerio M, Minhas S, Winkler M, Arya M, Ahmed HU.

Eur Urol. 2019 Jan 8. pii: S0302-2838(18)31036-4. doi: 10.1016/j.eururo.2018.12.030. [Epub ahead of print]

PMID:
30638633
7.

New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.

Schiano C, Soricelli A, De Nigris F, Napoli C.

Expert Rev Clin Immunol. 2019 Mar;15(3):289-301. doi: 10.1080/1744666X.2019.1561283. Epub 2019 Jan 2.

PMID:
30570412
8.

The evaluation of a hybrid biomechanical deformable registration method on a multistage physical phantom with reproducible deformation.

Qin A, Ionascu D, Liang J, Han X, O'Connell N, Yan D.

Radiat Oncol. 2018 Dec 4;13(1):240. doi: 10.1186/s13014-018-1192-x.

9.

Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, Bankson JA, Brindle K, Cunningham CH, Gallagher FA, Keshari KR, Kjaer A, Laustsen C, Mankoff DA, Merritt ME, Nelson SJ, Pauly JM, Lee P, Ronen S, Tyler DJ, Rajan SS, Spielman DM, Wald L, Zhang X, Malloy CR, Rizi R.

Neoplasia. 2019 Jan;21(1):1-16. doi: 10.1016/j.neo.2018.09.006. Epub 2018 Nov 23. Review.

10.

Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer.

Caglic I, Barrett T.

Transl Androl Urol. 2018 Oct;7(5):814-823. doi: 10.21037/tau.2018.08.04. Review.

11.

Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses.

Petralia G, Padhani AR, Pricolo P, Zugni F, Martinetti M, Summers PE, Grazioli L, Colagrande S, Giovagnoni A, Bellomi M; Italian Working Group on Magnetic Resonance.

Radiol Med. 2019 Mar;124(3):218-233. doi: 10.1007/s11547-018-0955-7. Epub 2018 Nov 14. Review.

PMID:
30430385
12.

Prostate imaging features that indicate benign or malignant pathology on biopsy.

Lovegrove CE, Matanhelia M, Randeva J, Eldred-Evans D, Tam H, Miah S, Winkler M, Ahmed HU, Shah TT.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S420-S435. doi: 10.21037/tau.2018.07.06. Review.

13.

Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer.

Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün PY, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H.

Ann Nucl Med. 2019 Jan;33(1):47-54. doi: 10.1007/s12149-018-1302-8. Epub 2018 Sep 15.

PMID:
30219990
14.

Imaging of distant metastases of prostate cancer.

Pesapane F, Czarniecki M, Suter MB, Turkbey B, Villeirs G.

Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2. Review.

PMID:
30218382
15.

Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.

Furlan A, Borhani AA, Westphalen AC.

Urol Clin North Am. 2018 Aug;45(3):439-454. doi: 10.1016/j.ucl.2018.03.009. Review.

PMID:
30031464
16.

Fundamentals of functional imaging I: current clinical techniques.

Luna A, Martín Noguerol T, Mata LA.

Radiologia. 2018 May;60 Suppl 1:2-22. doi: 10.1016/j.rx.2018.02.007. Epub 2018 Apr 12. English, Spanish.

17.

Multiparametric (mp) MRI of prostate cancer.

Kumar V, Bora GS, Kumar R, Jagannathan NR.

Prog Nucl Magn Reson Spectrosc. 2018 Apr;105:23-40. doi: 10.1016/j.pnmrs.2018.01.001. Epub 2018 Jan 31. Review.

PMID:
29548365
18.

Characterization and evaluation of a flexible MRI receive coil array for radiation therapy MR treatment planning using highly decoupled RF circuits.

McGee KP, Stormont RS, Lindsay SA, Taracila V, Savitskij D, Robb F, Witte RJ, Kaufmann TJ, Huston J 3rd, Riederer SJ, Borisch EA, Rossman PJ.

Phys Med Biol. 2018 Apr 13;63(8):08NT02. doi: 10.1088/1361-6560/aab691.

PMID:
29537384
19.

Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.

Furlan A, Borhani AA, Westphalen AC.

Radiol Clin North Am. 2018 Mar;56(2):223-238. doi: 10.1016/j.rcl.2017.10.005. Epub 2017 Nov 29. Review.

PMID:
29420978
20.

PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.

Razik A, Das CJ, Sharma S.

Indian J Urol. 2018 Jan-Mar;34(1):20-27. doi: 10.4103/iju.IJU_321_17. Review.

Supplemental Content

Loading ...
Support Center